Verastem, Inc. Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31)
Verastem, Inc. (VSTM) had Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) of $85.00 thousand as of 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Notes › Investments
us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain · last filed 2013-11-12
- 2013-09-30: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $85.00K.
- 2013-06-30: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $10.00K.
- 2013-03-31: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $18.00K.
- 2012-12-31: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $28.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) |
|---|---|
| 2013-09-30 | $85.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $10.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $18.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $28.00K 10-Q · filed 2013-11-12 |
| 2012-09-30 | $32.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $19.00K 10-Q · filed 2012-08-13 |
| 2011-12-31 | $6.00K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |